Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Corcept Therapeutics Stock (NASDAQ: CORT) stock price, news, charts, stock research, profile.
Open | - |
Close | - |
Volume / Avg. | 28.00 / 909.49K |
Day Range | - - - |
52 Wk Range | 20.84 - 39.75 |
Market Cap | $3.48B |
P/E Ratio | 31.00 |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 42 |
Short Interest | 29.04% |
Days to Cover | 23.2 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Corcept Therapeutics (NASDAQ:CORT) through any online brokerage.
Other companies in Corcept Therapeutics’s space includes: Novo Nordisk (NYSE:NVO), Merck & Co (NYSE:MRK), Johnson & Johnson (NYSE:JNJ), Novartis (NYSE:NVS) and Pfizer (NYSE:PFE).
Corcept Therapeutics has a consensus price target of $41.50.
The stock price for Corcept Therapeutics (NASDAQ: CORT) is $33.28 last updated September 10, 2024 at 7:10 PM EDT.
There are no upcoming dividends for Corcept Therapeutics.
Corcept Therapeutics’s Q3 earnings are confirmed for Wednesday, October 30, 2024.
There is no upcoming split for Corcept Therapeutics.
Corcept Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.